[go: up one dir, main page]

ATE334118T1 - Methode zur racemisierung von (s)-(+)- und (r)-(- )-10,11-dihydro-10-hydroxy-5h-dibenzeb,föazepin - 5-carboxamiden und optisch angereicherten mischungen davon - Google Patents

Methode zur racemisierung von (s)-(+)- und (r)-(- )-10,11-dihydro-10-hydroxy-5h-dibenzeb,föazepin - 5-carboxamiden und optisch angereicherten mischungen davon

Info

Publication number
ATE334118T1
ATE334118T1 AT04252724T AT04252724T ATE334118T1 AT E334118 T1 ATE334118 T1 AT E334118T1 AT 04252724 T AT04252724 T AT 04252724T AT 04252724 T AT04252724 T AT 04252724T AT E334118 T1 ATE334118 T1 AT E334118T1
Authority
AT
Austria
Prior art keywords
foeazepine
dibenzeb
racemization
carboxamides
dihydro
Prior art date
Application number
AT04252724T
Other languages
English (en)
Inventor
David Alexander Learmonth
Original Assignee
Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Portela & Ca Sa filed Critical Portela & Ca Sa
Application granted granted Critical
Publication of ATE334118T1 publication Critical patent/ATE334118T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04252724T 2003-05-12 2004-05-11 Methode zur racemisierung von (s)-(+)- und (r)-(- )-10,11-dihydro-10-hydroxy-5h-dibenzeb,föazepin - 5-carboxamiden und optisch angereicherten mischungen davon ATE334118T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0310856A GB2401605A (en) 2003-05-12 2003-05-12 Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof

Publications (1)

Publication Number Publication Date
ATE334118T1 true ATE334118T1 (de) 2006-08-15

Family

ID=9957887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04252724T ATE334118T1 (de) 2003-05-12 2004-05-11 Methode zur racemisierung von (s)-(+)- und (r)-(- )-10,11-dihydro-10-hydroxy-5h-dibenzeb,föazepin - 5-carboxamiden und optisch angereicherten mischungen davon

Country Status (20)

Country Link
US (1) US7189846B2 (de)
EP (1) EP1477480B1 (de)
JP (1) JP2006525985A (de)
KR (1) KR20060055456A (de)
CN (1) CN100519535C (de)
AR (1) AR044296A1 (de)
AT (1) ATE334118T1 (de)
AU (1) AU2004236022B2 (de)
BR (1) BRPI0410282A (de)
CA (1) CA2525419C (de)
DE (1) DE602004001627T2 (de)
DK (1) DK1477480T3 (de)
ES (1) ES2270293T3 (de)
GB (1) GB2401605A (de)
MX (1) MXPA05012209A (de)
PL (1) PL1477480T3 (de)
PT (1) PT103115A (de)
RU (1) RU2345986C2 (de)
SI (1) SI1477480T1 (de)
WO (1) WO2004099153A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2380574A1 (de) * 2005-05-06 2011-10-26 Bial-Portela & CA, S.A. Eslicarbazepinacetat und Verwendungsverfahren
US20060252745A1 (en) * 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0515690D0 (en) 2005-07-29 2005-09-07 Portela & Ca Sa Asymmetric catalytic reduction
GB2437078A (en) * 2006-04-11 2007-10-17 Portela & Ca Sa 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
WO2011014084A1 (en) 2009-07-27 2011-02-03 Bial - Portela & Ca., S.A. Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia
WO2011045648A2 (en) * 2009-10-12 2011-04-21 Matrix Laboratories Limited Process for preparing (s)-(-)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f]azepine-5-carboxamide and its esters thereof
EP2383261B1 (de) 2010-04-23 2013-09-04 Euticals GmbH Verfahren zur asymmetrischen Hydrierung von Ketonen
WO2012156987A2 (en) * 2011-05-19 2012-11-22 Glenmark Generics Limited A novel process for the preparation of eslicarbazepine
SG11201407300VA (en) * 2012-05-07 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of neurological disorders
EP3064490A1 (de) 2015-03-06 2016-09-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Verbessertes verfahren zur herstellung von eslicarbazepin und eslicarbazepinacetat
CN105130899A (zh) * 2015-08-25 2015-12-09 安徽省新星药物开发有限责任公司 一种醋酸艾司利卡西平的合成方法
FR3047172B1 (fr) * 2016-01-29 2020-05-08 Societe Industrielle Limousine D'application Biologique Agent cosmetique tenseur et/ou filmogene constitue par des galactomannanes et/ou des galactanes sulfates
CN116063231A (zh) * 2021-10-29 2023-05-05 上药康丽（常州）药业有限公司 一种s-利卡西平的回收方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605791A5 (de) * 1974-09-27 1978-10-13 Ciba Geigy Ag
CH642950A5 (en) 1979-10-30 1984-05-15 Ciba Geigy Ag Process for the preparation of 10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
PT101876B (pt) * 1996-05-27 1999-09-30 Portela & Ca Sa Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
GB0111566D0 (en) 2001-05-11 2001-07-04 Portela & Ca Sa Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide

Also Published As

Publication number Publication date
KR20060055456A (ko) 2006-05-23
MXPA05012209A (es) 2006-02-10
BRPI0410282A (pt) 2006-05-16
PL1477480T3 (pl) 2006-12-29
PT103115A (pt) 2004-11-30
EP1477480B1 (de) 2006-07-26
RU2005138516A (ru) 2007-06-20
JP2006525985A (ja) 2006-11-16
DK1477480T3 (da) 2006-11-27
AR044296A1 (es) 2005-09-07
US7189846B2 (en) 2007-03-13
CA2525419A1 (en) 2004-11-18
SI1477480T1 (sl) 2006-12-31
AU2004236022A1 (en) 2004-11-18
CA2525419C (en) 2014-07-22
GB0310856D0 (en) 2003-06-18
EP1477480A1 (de) 2004-11-17
RU2345986C2 (ru) 2009-02-10
AU2004236022B2 (en) 2010-09-23
GB2401605A (en) 2004-11-17
ES2270293T3 (es) 2007-04-01
DE602004001627T2 (de) 2007-08-23
CN1823047A (zh) 2006-08-23
US20040266754A1 (en) 2004-12-30
DE602004001627D1 (de) 2006-09-07
CN100519535C (zh) 2009-07-29
WO2004099153A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
ATE334118T1 (de) Methode zur racemisierung von (s)-(+)- und (r)-(- )-10,11-dihydro-10-hydroxy-5h-dibenzeb,föazepin - 5-carboxamiden und optisch angereicherten mischungen davon
DE602004008386D1 (de) System und Methode zur Herstellung von Brillengläsern, Programm und Medium
ATE500824T1 (de) Verfahren zur reinigung von trans-(-)-delta9- tetrahydrocannabinol und trans-(+)-delta9- tetrahydrocannabinol
DE60336238D1 (de) Verfahren zur herstellung von n-halbleiterdiamant und halbleiterdiamant
DE602004018714D1 (de) Verfahren zur Bereitstellung von zweiteiligen, selbstklebenden Dentalmassen
DE602004000224D1 (de) Medizinisches Adsorbent und Verfahren zur Herstellung
EP1540698A4 (de) System und verfahren zur herstellung von arrays biologischer oder anderer molek le
DE60301350D1 (de) Verfahren zur herstellung von 7-substituierten -3-chinolin und 3-chinol-4-on carbonitrile
DE60309087D1 (de) System und Methode zur Reglung von optischen Verstärkern
ATE437486T1 (de) Verfahren zur konfiguration von physischen kanälen
ATE411803T1 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
DE602005012405D1 (de) Verfahren zur chiralen inversion von (s)-(+)- und (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepin-5-carbonsäureamid und optisch angereicherten mischungen davon
DE60308976D1 (de) System und Methode zur Choreographie von Videosequenzen
DE60323579D1 (de) Methode zur Separierung von Nukleinsäuren und dafür verwendbare Reagenz
DE602004029434D1 (de) Brenner und Methode zur Herstellung von synthetischem Quarzglas
ATE480637T1 (de) Methode zur bestimmung der biologischen aktivität von difibrotid
DE502004007508D1 (de) Verfahren zur herstellung von bisepoxiden und dithiolen
ATE406372T1 (de) Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
EP1280516A4 (de) Methode zur transdermalen oder intradermalen verabreichung von molekülen
ATE538209T1 (de) L-threonin herstellendes bakterium und verfahren zur herstellung von l-threonin
DE50213742D1 (de) Verfahren zur verbesserung der funktionalität der binären repräsentation von mpeg-7 und anderen xml-basierten inhaltsbeschreibungen
DE60236649D1 (de) Methode zur entfernung von allergenen
DE60303877D1 (de) Verfahren zur Rückgewinnung von Phenol und Biphenolen
DE602004023969D1 (de) Methode zur herstellung von quervernetzten protein kristallen
FI20031678A0 (fi) Näytteen käsittelymenetelmä ja järjestely siihen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1477480

Country of ref document: EP

EEFA Change of the company name